Factor VIII inhibitors: von Willebrand factor makes a difference in vitro and in vivo

Publisher： John Wiley & Sons Inc

E-ISSN： 1538-7836|10|11|2328-2337

ISSN： 1538-7933

Source： JOURNAL OF THROMBOSIS AND HAEMOSTASIS, Vol.10, Iss.11, 2012-11, pp. : 2328-2337

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

von Willebrand factor: factor VIII protector and friend

By  

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, Vol. 10, Iss. 11, 2012-11 ,pp. : 2324-2327

John Wiley & Sons Inc

Access to resources Recommend Favorite

Factor VIII-von Willebrand Factor Binding Defects in Autosomal Recessive von Willebrand Disease Type Normandy and in Mild Hemophilia A

By  

Acta Haematologica, Vol. 121, Iss. 2-3, 2009-06 ,pp. : 102-105

Karger

Access to resources Recommend Favorite

Epsilon-Aminocaproic Acid Inhibits the Activity of Factor VIII Inhibitors in Patients with Severe Haemophilia A in vivo and in vitro

By  

Acta Haematologica, Vol. 103, Iss. 2, 2000-05 ,pp. : 67-72

Karger

Access to resources Recommend Favorite

6 Factor VIII Concentrates, Factor VIII/von Willebrand Factor Concentrates, Factor IX Concentrates, Activated Prothrombin Complex Concentrates

By  

Transfusion Medicine and Hemotherapy, Vol. 36, Iss. 6, 2009-12 ,pp. : 409-418

Karger

Access to resources Recommend Favorite

Managing Patients with von Willebrand Disease Type 1, 2 and 3 with Desmopressin and von Willebrand Factor-Factor VIII Concentrate in Surgical Settings

By  

Acta Haematologica, Vol. 121, Iss. 2-3, 2009-06 ,pp. : 167-176

Karger

Access to resources Recommend Favorite